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Mesenchymal chondrosarcoma (MC) is a rare variant of chondrosarcoma (CS) that accounts for upto 3-9% of all 
CS and has high predilection for the head and neck region. It is usually seen in younger age group compared to 
conventional CS and maxillary anterior alveolus is the most common site. The tumor is most unusual as it has 
been described as a particularly aggressive neoplasm with a high tendency for late recurrence and delayed metas-
tasis. It is a biphasic tumor with areas comprising of spindle cell mesenchyme interspread with areas of chondroid 
differentiation. A 75 year old male presented to us as a painless mass in maxilla. Contrast enhanced computed 
tomography (CECT) revealed a lytic expansile lesion in the left maxillary bone with foci of calcification within 
soft tissue lesion. Fine needle aspiration cytology (FNAC) and incisional biopsy was performed which confirmed 
the diagnosis of maxillary MC. The patient underwent right and left subtotal maxillectomy with 2 cm margins. 
The review of literature shows that very few cases of maxillary MC have been reported so far. Thus an attempt is 
made to add this rare case of MC of maxillary alveolus in the English literature.
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Introduction    
Chondrosarcoma (CS) is a malignant tumor character-
ized by the formation of cartilage and usually arises in 
peripheral long and flat bone (1,2). It accounts for ap-
proximately 
10-20% of malignant bone tumors (2). Head and neck 
CS is an uncommon entity accounting for approxi-
mately 0.1% of all head and neck cancers (3). Several 
variants of CS have been proposed including clear cell, 
dedifferentiated, myxoid and mesenchymal (3-5).  Mes-
enchymal chondrosarcoma (MC) is a rare variant of 
CS that accounts for up to 3-9% of all CS and has high 
predilection for the head and neck region. It is usually 
seen in younger age group compared to conventional 
CS (6). The tumor is most unusual as it has been de-
scribed as a particularly aggressive neoplasm with a 
high tendency for late recurrence and delayed metasta-
sis (3,6). The review of literature shows that a very few 
cases of maxillary MC have been reported so far in the 
English literature. Here an additional rare case of MC 
of maxillary alveolus in 75 year old patient is reported 
and discussed.
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Case Report
A 75 year old male patient presented to our department 
with a chief complaint of a painless growth in the left 
maxillary alveolar region since 4 months. The patient 
was apparently well 4 months back when he noticed a 
small growth in his left maxillary alveolus which grew 
rapidly to the present dimensions. As the lesion was 
asymptomatic initially the patient neglected it but as it 
continued to grow in size he became concerned and vis-
ited our institute for the management of the same. His 
medical history revealed that he was hypertensive since 
6 years and was on regular medications for the same. 
Also, he had been operated for inguinal hernia 2 years 
back. Extraoral examination revealed a well defined 
firm swelling in relation to upper anterior face raising 
the upper lip. It extended from ala of the nose superi-
orly to vermillion of upper lip inferiorly and midline 
of nose anteriorly to a line drawn downwards from the 
midpupillary point posteriorly on the left side of face. 
The skin over the swelling was smooth and appeared 
to be stretched with no surface ulcerations or raised 
temperature.  Intraoral examination revealed two sepa-
rate lobulated swellings arising from the left maxillary 
alveolar region (Fig. 1). The buccal swelling extended 
anterior-posteriorly from distal aspect of 21 to mesial 
aspect of 26 and medio-laterally from buccal sulcus to 
palatal alveolus causing expansion of the buccal cortical 
plate and obliterating the buccal sulcus. The swelling 
measured approximately about 2x3 cm in dimensions 
and caused gross buccal displacement of 23 and 24. 
The palatal swelling extended anterior-posteriorly from 
mesial aspect of 21 to distal aspect of 26 and medially 
from 0.5 cm from mid-palatal region on the same side 
to the palatal alveolus laterally measuring approximate-
ly 1.5x3 cm in dimensions. The buccal swelling was 
firm to hard in consistency with mucosa over swelling 
smooth and stretched. The palatal swelling was firm in 
consistency with superficial surface necrosis. There was 
no significant associated lymphadenopathy associated 
with the lesion. FNAC from the lesion was carried out 
which revealed chondroid matrix suggesting chondroid 
tumor. CECT revealed a lytic expansile lesion in the left 
maxillary bone extending medially upto midline and 
laterally extending into gingivobuccal sulcus (Fig. 2). 
Anterioposterior extension was from central incisor to 
first molar on the left side. There were foci of calcifica-
tion within soft tissue lesion but there was no evidence 
of significant lymphadenopathy.
To confirm the diagnosis incisional biopsy was under-
taken. While giving incision on the lesion a hard calci-
fied tissue was felt which was included in the biopsy 
along with the soft tissue specimen. Histopathology 
study revealed cellular connective tissue stroma with 
spindle shaped cells arranged in lobular pattern. The 
cells showed dysplastic features with increased mitotic 
figures. Large areas of chondroid matrix with areas of 
calcification were also seen (Fig. 3). Overall histopatho-
logic picture suggested mesenchymal chondrosarcoma 
of maxilla.
Fig. 1. Intraoral view of the lesion showing bucco-palatal ex-
tension and causing displacement of 23 and 24 buccally.
Fig. 2. CT scan (axial view) shows bucco-palatal extension of 
the lesion with displacement of 23 and 24 and foci of calcifi-
cations both buccally and palatally.
Fig. 3. Histopathology revealed cellular connective tissue stro-
ma with spindle shaped cells interspersed with lacunar cells in 
a chondroid matrix with areas of calcification.
Med Oral Patol Oral Cir Bucal. 2011 Jul 1;16 (4):e493-6.                                                                                                                                                   Mesenchymal Chondrosarcoma of maxilla          
e495
The patient was operated under general anesthesia and 
underwent right and left subtotal maxillectomy tak-
ing 2 cm margin overall and remnants of nasal mucosa 
was sutured with antral mucosa. The palatal defect was 
closed with a medicated gauze pack place under palatal 
surgical splint. Post healing palatal obturator was fab-
ricated to close oro-nasal communication. The patient 
is under observation and after 9 months of follow up is 
doing well.
Discussion
MC is a rare variant of CS that was first described by 
Lichenstein and Bernstein in 1959 as a biphasic tumor 
with areas comprising of spindle cell mesenchyme inter-
spread with areas of chondroid differentiation (3, 5-8). 
Although considered to be rare the jaw bones constitute 
the most common location for MC (7,9). 
CS has been considered to be malignant tumor histoge-
netically derived from mature cartilaginous tissue (10). 
Since maxilla is a bone of exclusive membranous ossifi-
cation; the possibility of CS is therefore surprising and 
has been explained by the vestigial nests of cartilage 
having source from (11)
1.  cartilage found in incisive papilla
2.  vestigial cartilage remnants in periodontal ligament
3.  foci of cartilage from cartilaginous nasal capsule
4.  paraseptal cartilage.
The present school of thought, however, says that CS 
may be derived either from cartilaginous tissue reserve 
cells (primary CS) or from primitive mesenchymal 
cells displaying chondromatous differentiation. Thus it 
explains that CS maxilla is derived from cartilaginous 
differentiation of primitive mesenchymal cells rather 
than from embryonal cartilaginous nests (10).
Most chondrosarcomas of the head and neck region oc-
cur in the maxilla; others are found in descending order 
of frequency in the body of the mandible, the ramus, the 
nasal septum, and the paranasal sinuses. In the maxilla 
the most common location is anterior alveolus where 
pre-esisting nasal cartilage is present (12,13). Our re-
ported case initially occurred in maxillary anterior 
region but as the lesion expanded it involved posterior 
part of jaw as well.
Although CS occurs most often in 3rd-6th decade of life, 
the MC variant occurs in 2nd-3rd decade of life in 70% of 
cases (6,9,12). Very few cases have been reported to oc-
cur beyond the 6th decade (5,6). Our reported case falls 
in this rare category of occurrence beyond the 6th dec-
ade of life.
There is some discrepancy in the literature regarding 
gender distribution in cases of MC. There are some re-
ports indicating equal prevalence between sexes while 
others showing a slight male prevalence (5).  Our re-
ported case occurred in a male patient.
The most common clinical presentation of MC of jaws 
is a painless mass or swelling  in comparison to its oc-
currence elsewhere in the body where pain and swelling 
are the most common presenting symptoms (6, 12-15). 
In a study of 36 MC of maxilla by Niven et al. the most 
common reported symptom was swelling/mass in 68% 
of cases, followed by nasal obstruction (32%), epistaxis 
(32%) and tooth mobility ( 24%) (7). Our reported case 
also presented to us as a painless mass in the palate with 
grade I mobility of the involved teeth.
In the same study by Niven et al. they found that the du-
ration of signs and symptoms before diagnosis ranged 
from 2 weeks-4 years and in most cases, did not exceed 
but a few months. Our case was presented and diag-
nosed after a period of 4 months (7).
The radiographic features of MC are not characteris-
tic. The tumor usually shows features of a malignancy, 
consisting of a radiolucent process with poorly defined 
borders. The radiolucent area often contains scattered 
foci, which are caused by calcification or ossification 
of the cartilage matrix. It often demonstrates extensive 
infiltration between the osseous trabeculae of the preex-
isting bone without causing appreciable resorption. The 
lesion may also cause symmetrical widenening of the 
periodontal ligament space of the involved teeth (14). 
Our case in discussion showed similar radiographic ap-
pearance of an ill defined lytic lesion with radio-opaque 
sclerotic foci in the maxillary alveolus without causing 
root resorption.
The histologic appearance of MC is characteristically 
biphasic pattern. Undifferentiated areas appear as sheets 
of primitive mesenchymal spindle/round cells similar to 
small cell anaplastic sarcoma. However, islands of rela-
tively well differentiated cartilaginous tumor help in 
making a specific diagnosis (6). Calcification or ossifica-
tion may occur within the chondroid matrix. Neoplastic 
cartilage may be replaced by bone in a manner similar 
to normal endochondral ossification. Histologically the 
lesion must be differentiated from similar other lesions 
like hemangiopericytoma, Ewing’s sarcoma, PNET, 
leukemia/lymphoma, rhabdomyosarcoma, malignant 
melanoma and small cell osteocarcoma (7). Evans and 
coworkers have classified CS into grades I, II and III 
on the basis of mitotic rate, cellularity and nuclear size 
(12). Grade I lesions resembles benign cartilage and 
they do not metastasize. Grade II lesions demonstrate 
more myxoid stroma. They recur locally more often 
than grade I lesions and have 10% incidence of metasta-
sis. Grade III lesions have a more cellular pleomorphic 
appearance. They have a spindle cell proliferation with 
a marked increase in number of mitotic figures. The in-
cidence of metastasis in these lesions is more than 70% 
(1). Our case showed histologic picture of highly cel-
lular CT stroma of spindle/stellate cells with increased 
mitotic figures suggestive of grade III lesion.
With regards to therapy, various treatment modalities 
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have been reviewed. The treatment of choice is surgical 
resection with wide margins. The overall low incidence 
of regional metastasis may suggest that neck dissection 
is not indicated (13,14). Radiotherapy might play a role 
when accompanied by surgery although some believe 
MC to be a radioresistant tumor. Chemotherapy has a 
limited role in chondrosarcoma and should be used as 
an adjuvant therapy in cases with aggressive behavior 
with potential metastasis, rapid local recurrence and 
high grade lesions (5,13). 
In general the prognosis for patients with MC is poor 
because of the tumor’s tendency to local recurrences or 
metastasis even after a long disease free interval. An 
interval as a long as 20 years have been reported before 
recurrence or metastasis occurred. The principal sites 
of metastasis are the lungs and bone. The reported 5 
year and 10 year survival rate is 48% and 28% respec-
tively (5).
Although the patient in present case was treated surgical-
ly with wide margins of resection and is doing well pres-
ently but knowing the notorious nature of MC in jaws the 
patient is kept under a close long term follow up.
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